Number of shares to be issued: 15,99,270 equity shares
Face value: ₹10 per share
Issue price: Not less than ₹280 per share
Total issue size: Approximately ₹44.78 crore (15,99,270 shares × ₹280)
Parties Involved
Issuer: Aptus Pharma Limited
Regulatory authority: BSE Limited
Recipients: Promoters and non-promoters (unspecified names)
Compliance Requirements and Conditions
The company must ensure issue and allotment complies with all applicable laws and regulations
Must strengthen internal controls to monitor trades by proposed allottees in the company's scrip
Required to obtain undertaking from allottees confirming they will not do intra-day trading or any sale in the company's scrip until allotment date
Responsibility for verification and compliance rests solely with the issuer company
Must make listing application within 20 days from date of allotment as per SEBI circular
Non-compliance may impact listing of shares and attract fines
BSE reserves right to withdraw approval if information is found incomplete/incorrect/misleading/false
Financial and Capital Structure Impact
The preferential issue will result in dilution of existing shareholding through issuance of 15,99,270 new equity shares
The issue will bring approximately ₹44.78 crore in fresh equity capital to the company
Post-issue share capital impact not quantified in the disclosure
Additional Information
The in-principle approval does not constitute approval for listing of the securities
Company must separately comply with listing requirements under Regulation 14 of LODR Regulations
For convertible securities, excess lock-in period of pre-preferential holding will be automatically released by depositories without requiring NOC from Exchange
Company address: Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat-382427
